Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease
Go back to Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease| Amgen Inc (NASDAQ: AMGN) | Delayed: 351.43 +4.42 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $347.01 | 52 Week High | $176.85 | |||
| Open | $348.00 | 52 Week Low | $133.64 | |||
| Day High | $354.42 | P/E | 52.93 | |||
| Day Low | $346.00 | EPS | $6.64 | |||
| Volume | 2,391,877 | |||||
| Powder River Basin & Gas Corporation (NASDAQ: PRVB) | Delayed: 24.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.98 | 52 Week High | $0.17 | |||
| Open | $41.76 | 52 Week Low | $0.17 | |||
| Day High | $24.98 | P/E | 499.60 | |||
| Day Low | $24.98 | EPS | $0.05 | |||
| Volume | 9,073,039 | |||||
